Disease / condition
Cardiovascular Disease clinical trials
Free access to 357 studies·10+ countries·Updated daily16 recruiting
357
Total trials
10+
Countries
10+
Sponsors
16
Recruiting
By phase
N/A247
Phase 133
Phase 321
Phase 421
Phase 217
By status
Completed265
Unknown28
Recruiting16
Terminated13
Not yet recruit...13
Top countries
United States of America129
United Kingdom38
Canada25
China13
France11
Top sponsors
Penn State Univers...12
AstraZeneca11
National Heart, Lu...10
GlaxoSmithKline8
University of Read...7
Recent trials
Latest clinical trials for Cardiovascular Disease
SLCTR_2022_016·Not ApplicableRecruiting
Randomized crossover controlled clinical trial to assess the comparative acute effects of saturated fat rich meal (coconut fat and butter) with unsaturated fat rich meal (sesame oil) on vascular reactivity, blood pressure, plasma lipids and markers of insulin resistance in healthy adult men.
Wayamba University Research Gr...Sri Lanka
PHRR200909-002920·Phase 3Terminated
A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease
Novartis Healthcare Philippine...Australia;China;Denmark;Germany;Hong;Kong;India;Japan;Malaysia;Poland;Singapore;United;States
NCT06413823Recruiting
Prevention and Treatment of Cardiovascular Disease
IRCCS Centro Neurolesi Bonino-...Italy
NCT06263452·Phase 4Not yet recr...
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
University of North Carolina, ...United States of America
NCT05972850Not yet recr...
Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease
Wake Forest University Health ...United States of America
NCT05904639·Phase 1Not yet recr...
Decoding Your Diet (DYD)
Morehouse School of MedicineUnited States of America
2022-003060-25Ongoing
Open-label, multicenter, multinational, interventional Clinical Trial to assess Efficacy and Safety of the extemporaneous combination of Nebivolol and Ramipril in hypertensive patients - ARTEMISIA study
Menarini International Operati...
2021-003059-41Ongoing
A randomized, double-blind, placebo-controlled, multicenter trial assessing the reduction of the rate of lipoprotein apheresis after treatment with pelacarsen (TQJ230) compared to placebo in patients with hyperlipoproteinemia(a) and established cardiovascular disease undergoing weekly lipoprotein apheresis in Germany
Novartis Pharma AG
NCT05361421·Phase 4Recruiting
Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial
Yonsei UniversitySouth Korea
KCT0007029·Not ApplicableCompleted
Untitled Trial
Korea UniversitySouth Korea
NCT05214989Not yet recr...
Tailored Interventions to Increase Cardiac Rehabilitation Enrollment
VA Office of Research and Deve...United States of America
NCT04927429Recruiting
Technical Development of Cardiovascular Magnetic Resonance Imaging
National Heart, Lung, and Bloo...United States of America
jRCT2031200367Completed
Untitled Trial
Amgen K.K.Australia;Canada;Iceland;United States of America;Denmark;Netherlands
NCT04749927Recruiting
Deep Learning of Retinal Photographs and Atherosclerotic Cardiovascular Disease
Yonsei UniversitySouth Korea
NCT04717336·Early Phase 1Recruiting
Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African Americans Study (GENE-FORECAST): Sodium Intervention Trial (SIT)
National Human Genome Research...United States of America
NCT04686591·Phase 1Completed
Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male Subjects
AstraZenecaUnited Kingdom
ChiCTR2000039640·Early Phase 1Recruiting
Untitled Trial
Beijing Tsinghua Changgung Hos...China
NCT04611932·Phase 1Not yet recr...
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers
Chong Kun Dang PharmaceuticalSouth Korea
NCT04588727·Phase 1Recruiting
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects
AstraZenecaUnited States of America
NCT04492709·Phase 1Completed
A Study to Assess the Effect of Multiple Doses of AZD5718 on Pharmacokinetics of Oral Midazolam in Healthy Subjects
AstraZenecaUnited Kingdom
About this record
Access comprehensive clinical trial information for Cardiovascular Disease through Pure Global AI's free database. This collection includes 357 clinical trials across multiple phases including N/A, Phase 1, Phase 3. Currently, 16 trials are actively recruiting participants.
Research for Cardiovascular Disease is being conducted in United States of America, United Kingdom, Canada and 7+ other countries. Leading sponsors include Penn State University and AstraZeneca. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 357 clinical trials studying Cardiovascular Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Penn State University, AstraZeneca, National Heart, Lung, and Blood Institute (NHLBI), among others.